Product/Composition:- | Cabergoline |
---|---|
Strength:- | 0.25 mg, 0.5 mg |
Form:- | Tablets |
Reference Brands:- | Dostinex®, Cabaser® |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Cabergoline is a dopamine agonist used for hyperprolactinemia and Parkinson’s disease, available in 0.25 mg and 0.5 mg tablets. Brands include Dostinex® and Cabaser®. Pharma B2B suppliers offer bulk Cabergoline from GMP-certified facilities, ensuring regulatory compliance, quality assurance, and consistent supply for global pharmaceutical distributors and hospitals.
Cabergoline is a potent dopamine agonist used to treat hyperprolactinemia and manage symptoms in Parkinson’s disease. Available primarily as 0.25 mg and 0.5 mg oral tablets, it is marketed under brands like Dostinex® and Cabaser® in the US and EU. Cabergoline works by reducing prolactin levels through D2 receptor stimulation. Pharma B2B buyers can access Cabergoline from GMP-certified manufacturers, ensuring reliable quality, regulatory approvals (US FDA, EU GMP), and scalable bulk supply. Ideal for hospital tenders, specialty distributors, and endocrinology-focused pharmaceutical partners looking for a trusted Cabergoline source in regulated and semi-regulated markets.